These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2919174)

  • 1. Fourier analysis of cell motility: correlation of motility with metastatic potential.
    Partin AW; Schoeniger JS; Mohler JL; Coffey DS
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1254-8. PubMed ID: 2919174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model.
    Doyle GM; Sharief Y; Mohler JL
    J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
    Mohler JL; Partin AW; Isaacs JT; Coffey DS
    Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL; Levy F; Sharief Y
    Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model.
    Mohler JL; Partin AW; Coffey DS
    J Urol; 1987 Jul; 138(1):168-70. PubMed ID: 3599207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assay of pinocytosis: correlation with membrane ruffling and metastatic potential in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL; Sharief Y
    Cytometry; 1993 Oct; 14(7):826-31. PubMed ID: 8243212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.
    Partin AW; Isaacs JT; Treiger B; Coffey DS
    Cancer Res; 1988 Nov; 48(21):6050-3. PubMed ID: 3048653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of metastatic potential of aspirated cells from the Dunning R-3327 prostatic adenocarcinoma model.
    Doyle GM; Mohler JL
    J Urol; 1992 Mar; 147(3):756-9. PubMed ID: 1538478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time lapse videomicroscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells.
    Mohler JL; Partin AW; Isaacs WB; Coffey DS
    J Urol; 1987 Mar; 137(3):544-7. PubMed ID: 3820394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
    Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
    Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility.
    Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB
    J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer.
    Donald CD; Cooper CR; Harris-Hooker S; Emmett N; Scanlon M; Cooke DB
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1033-8. PubMed ID: 11785653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface charge.
    Carter HB; Partin AW; Coffey DS
    J Urol; 1989 Nov; 142(5):1338-41. PubMed ID: 2810530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cells.
    Partin AW; Mohler JL; Coffey DS
    Cancer Treat Res; 1992; 59():121-30. PubMed ID: 1347689
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines.
    Shestakova EA; Wyckoff J; Jones J; Singer RH; Condeelis J
    Cancer Res; 1999 Mar; 59(6):1202-5. PubMed ID: 10096548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion and invasion potential of rat prostatic cancer cells: correlation with metastatic potential.
    Cooper CR; Donald C; Emmett N; Harris-Hooker S; Cooke DB
    Invasion Metastasis; 1993; 13(4):178-84. PubMed ID: 8034439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of prognosis to nuclear roundness and to flow cytometric light scatter.
    Mohler JL; Partin AW; Coffey DS
    Anal Quant Cytol Histol; 1987 May; 9(2):156-64. PubMed ID: 3300686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular motility and prostatic carcinoma metastases.
    Mohler JL
    Cancer Metastasis Rev; 1993 Mar; 12(1):53-67. PubMed ID: 8448827
    [No Abstract]   [Full Text] [Related]  

  • 20. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
    Sheng S; Carey J; Seftor EA; Dias L; Hendrix MJ; Sager R
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11669-74. PubMed ID: 8876194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.